Patrick Amstutz
Founder at MOLECULAR PARTNERS AG
Net worth: 3 M $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Tobias Stumpp | M | 52 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 20 years |
| William Burns | M | 76 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 7 years |
| Vito Palombella | M | 61 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 years |
| Steven Holtzman | M | 70 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 10 years |
| Michael Vasconcelles | M | 61 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 years |
| Sandipkumar S. Kapadia | M | 54 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 years |
| Dominik Höchli | M | 57 | 3 years | |
| Andreas Emmenegger | M | 58 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 17 years |
| Gwen A. Fyfe | M | 72 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 5 years |
| Agnete Brunsvik Fredriksen | M | 47 | 3 years | |
| Seth D. Lewis | M | - | 5 years | |
| Daniel Steiner | M | - | 13 years | |
| Alexander Zürcher | M | - | 2 years | |
| Philippe Legenne | M | - | 4 years | |
| Renate Gloggner | F | - | 3 years | |
| Jurgi Camblong | M | 45 |
Swiss Biotech Association
 Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | - |
| Baris Arican | M | - | 2 years | |
| Robert Kuster | M | - |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | - |
| Michael Altorfer | M | - |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | 6 years |
| Michael Pitzner | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrik Forrer | M | - | - | |
| Christian Zahnd | M | 49 | 12 years | |
| Dominik Escher | M | - |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | - |
| Andreas Plückthun | M | 65 | - | |
| Göran Albert Ando | M | 75 | 10 years | |
| William Lee | M | 69 | 13 years | |
| Jeffrey H. Buchalter | M | 67 | 2 years | |
| Jörn Aldag | M | 65 | 11 years | |
| Petri T. Vainio | M | 65 | 11 years | |
| Pamela A. Trail | M | 68 | 1 years | |
| Martin Kawe | M | - | - | |
| Kaspar Binz | M | - | - | |
| Andreas Harstrick | M | 63 | 4 years | |
| Lisa Rojkjaer | M | 58 | - | |
| Nicolas Leupin | M | 50 | 4 years | |
| Julien Gander | M | 45 | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 36 | 100.00% |
| United States | 8 | 22.22% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Patrick Amstutz
- Personal Network
